Abstract
The study included 418 of the 841 clinical isolates of S. aureus, which were regarded as nosocomial. These 418 clinical nosocomial S. aureus strains were isolated in 2013-2014 from patients hospitalized in 25 hospitals in 19 Russian cities. Methicillin-resistance rate was 24.9% (n=104). Antimicrobials with the highest activity with no resistance detected were vancomycin, linezolid, cefilavancin, telavancin, daptomycine, tigecycline and fusidic acid. Other highly in-vitro active antimicrobials were trimethoprim-sulfamethoxazole, mupirocin and ceftaroline (0.5%, 2.2% and 4.3% non-susceptible isolates respectively). MRSA isolates were substantially less susceptible compare with MSSA to gentamicin (1.3% vs. 83.7%), clindamycin (1.6% vs. 40.4%), rifampicin (2.2% vs. 27.9%), tetracycline (12.1% vs. 35.6%), chloramphenicol (9.9% vs. 71.2%), ceftaroline (0% vs. 17.3%), ciprofloxacin (6.1% vs. 89.4%), and erythromycin (18.5% vs. 58.7%).
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Institute of Antimicrobial Chemotherapy, Smolensk, Russia
Rozanova S.M., Perevalova E.YU., Yaranceva N.Z. (Ekaterinburg)
Novikova R.I., Moldovanu M.G. (Izhevsk)
Valiullina I.R., Nasybullova Z.Z. (Kazan)
Arhipenko M.V., Adonina E.E., Petrova L.V., Nizhegorodceva I.A. (Krasnodar)
Lazareva A.V., Kryzhanovskaya O.A., Popov D.A., Zemlyanoj A.B., Zubrickij V.F., Aleksandrova I.A. (Moscow)
Gordeeva S.A., CHernyavskaya YU.L. (Murmansk)
Kirillova G.SH. (Noyabrsk)
Popova L.D., Elohina E.V. (Omsk)
Markelova N.N., Smolkova YU.E. (Penza)
Anikina I.N. (Petrozavodsk)
Shigorceva N.G., Zykova T.A., Kucevalova O.YU., Panova N.I. (Rostov-on-Don)
Borisov A.M., Bozhkova S.A., Suborova T.N., Poluhina O.V. (Saint-Petersburg)
Krechikova O.I. (Smolensk)
Shetinin E.V. Alieva E.V. (Stavropol)
Martyanova N.M. (Tolyatti)
Vunukajnen T.M., Gudkova L.V., Volkovskaya I.V. (Tomsk)
Hohlyavin R.L., Habibrahmanova D.F. (Tyumen)
Burasova E.G., Hrebtovskaya V.A. (Ulan-Ude)
Molchanova I.V. (Chelyabinsk)
SHamaeva S.H., Portnyagina U.S., Bryzgalova V.I., Yadreeva O.N. (Yakutsk)
-
1.
Сухорукова МВ, Склеенова ЕЮ, Иванчик НВ, Тимохова АВ, Эйдельштейн МВ, Дехнич АВ. Козлов РС. Антибиотикорезистентность нозокомиальных штаммов Staphylococcus aureus в стационарах России: результаты многоцентрового эпидемиологического исследования МАРАФОН в 2011-2012 гг. Клин микробиол антимикроб химиотер 2014;16:280-6.
-
2.
Дехнич АВ, Эйдельштейн ИА, Нарезкина АД, и соавт. Эпидемиология антибиотикорезистентности нозокомиальных штаммов Staphylococcus aureus в России: результаты многоцентрового исследования. Клин микроб и антимикроб химиотер 2002;4:325-36.
-
3.
Dekhnich AV, Ryabkova EL, Kretchikova OI, Sukhorukova MV, Stratchounski LS. Antimicrobial Resistance of Nosocomial Strains of Staphylococcus aureus in Russian ICUs: Results of Multicenter Study. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 Sep 27-30; San Francisco, CA, USA. Abstract K-794.
-
4.
Дехнич АВ, Никулин АА, Рябкова ЕЛ, Кречикова ОИ, Сухорукова МВ, Козлов РС, исследовательская группа РОСНЕТ. Эпидемиология резистентности штаммов S. aureus, выделенных от пациентов в ОРИТ российских стационаров: результаты многоцентрового исследования. Клин микробиол антимикроб химиотер 2008;10:333-44.
-
5.
Dekhnich A, Nikulin A, Ivanchik N, Kretchikova O, Kozlov R. Susceptibility of Staphylococcus aureus nosocomial isolates in Russia: five-year trends. Proceedings of the 19th European Congress of Clinical Microbiology and Infectious Diseases; 2009 May 16-19; Helsinki, Finland. Abstract P1076.
-
6.
Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008;3:163-75.
-
7.
Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001;48(S1):5-16.
-
8.
ISO 20776-1:2006 Clinical laboratory testing and in vitro diagnostic test systems – Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices – Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases.
-
9.
Национальный Стандарт ГОСТ Р ИСО 20776-1-2010 Клинические лабораторные исследования и диагностические тест-системы in vitro. Исследование чувствительности инфекционных агентов и оценка функциональных характеристик изделий для исследования чувствительности к антимикробным средствам. Часть 1. Референтный метод лабораторного исследования активности антимикробных агентов против быстрорастущих аэробных бактерий, вызывающих инфекционные болезни.
-
10.
Клинические рекомендации «Определение чувствительности микроорганизмов к Антимикробным препаратам». Версия 2015-02 (http://www.antibiotic.ru/minzdrav/files/docs/clrec-dsma2015.pdf).
-
11.
Olearoa F, Albrichb WC, Vernaza N, Harbartha S, Kronenbergc A, and the Swiss Centre for Antibiotic resistance (ANRESIS). Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly 2016;146:w14339.
-
12.
Pastuović T, Perić M, Bošnjak Z1 Ružman N1 Majić PR, Talapko J, Atalić V, Loci-Zvocak S, Vuković D Methicillin-resistant Staphylococcus aureus in North-east Croatia. Acta Med Acad 2015;44:10-7.
-
13.
Centers for disease control and prevention. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Methicillin-Resistant Staphylococcus aureus, 20
-
14.
https://www.cdc.gov/abcs/reportsfindings/survreports/mrsa14.pdf.